Corteva (NYSE:CTVA) Releases FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 3.450-3.700 for the period, compared to the consensus estimate of 3.230. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.4 billion.

Analysts Set New Price Targets

Several research firms have issued reports on CTVA. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 22nd. Oppenheimer set a $86.00 price objective on shares of Corteva in a research note on Thursday. UBS Group decreased their price target on Corteva from $85.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, October 30th. Mizuho upped their price target on shares of Corteva from $78.00 to $80.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Corteva from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average target price of $81.53.

Corteva Trading Down 3.5%

Corteva stock traded down $2.60 during midday trading on Thursday, hitting $72.52. 1,894,156 shares of the stock were exchanged, compared to its average volume of 3,914,905. The company has a current ratio of 1.58, a quick ratio of 1.07 and a debt-to-equity ratio of 0.07. The stock’s 50-day simple moving average is $68.60 and its 200 day simple moving average is $68.40. Corteva has a fifty-two week low of $53.40 and a fifty-two week high of $77.41. The stock has a market capitalization of $49.01 billion, a price-to-earnings ratio of 45.89, a PEG ratio of 1.91 and a beta of 0.75.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 8.97%. Corteva’s revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: RBC Capital raised its price target to $89 (from $80) and kept an “outperform” rating — a bullish analyst signal that implies ~22% upside from recent levels. MarketScreener
• Positive Sentiment: Corteva raised FY‑2026 EPS guidance to $3.45–$3.70, above consensus (~$3.23), and highlighted strong full‑year cash generation — forward guidance and cash flow outlook are supportive for longer‑term valuation. PR Newswire
• Positive Sentiment: Company materials and press coverage emphasize record free cash flow and strategic execution in FY‑2025, which investors prize for buybacks/debt reduction potential. Yahoo Finance
• Neutral Sentiment: Q4 EPS of $0.22 matched consensus, removing an immediate earnings surprise — the beat on EPS but decline vs. prior year is mixed for sentiment. MarketBeat
• Neutral Sentiment: Full earnings package and call transcript/slide deck are available for detail-oriented investors; use these to assess margin drivers and product mix. Seeking Alpha Transcript
• Negative Sentiment: Revenue missed expectations ($3.91B vs. $4.23B est.) — management cited seasonal timing shifts and weaker crop‑protection/seed demand, which has near‑term negative implications for top‑line momentum. Investing.com
• Negative Sentiment: Shares fell after hours on the revenue miss and wider loss commentary in some reports — short‑term selling pressure followed the print. Seeking Alpha
• Negative Sentiment: JPMorgan downgraded the stock from “overweight” to “neutral” (PT modestly raised to $77) — the rating cut is a signaling headwind even though their target is above current levels. Finviz (JPMorgan note)

Institutional Trading of Corteva

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Kelleher Financial Advisors lifted its position in Corteva by 3.8% in the third quarter. Kelleher Financial Advisors now owns 4,594 shares of the company’s stock valued at $311,000 after buying an additional 170 shares during the last quarter. Binnacle Investments Inc lifted its holdings in shares of Corteva by 54.7% in the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after acquiring an additional 181 shares during the last quarter. Cresset Asset Management LLC boosted its position in shares of Corteva by 2.6% during the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the period. Sunbelt Securities Inc. raised its position in Corteva by 52.8% in the third quarter. Sunbelt Securities Inc. now owns 923 shares of the company’s stock valued at $62,000 after purchasing an additional 319 shares during the period. Finally, JPL Wealth Management LLC acquired a new position in Corteva during the third quarter worth $25,000. 81.54% of the stock is owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.